A consideration of genetic mechanisms behind the development of hypertension in blacks

Current Hypertension Reports

Volumn 15, Issue 2, 2013, Pages 108-113

  Tu, Wanzhu ^a   Pratt, J Howard ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Aldosterone; Angiotensin II; Angiotensinogen; APOL 1; Calcium; Calcium sensing receptor; Epithelial sodium channel; Extracellular fluid volume; Hypertension; MYH9; NKCC2; Potassium; Proximal tubule; Race; Renin; Sodium; Thick ascending limb

Indexed keywords

ALDOSTERONE; ANGIOTENSINOGEN; SODIUM; SODIUM POTASSIUM CHLORIDE COTRANSPORTER;

APOL 1 GENE; BLOOD PRESSURE; DISEASE ASSOCIATION; EPIGENETICS; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY TUBULE ABSORPTION; MYH9 GENE; NEGRO; NEPHRON; PHENOTYPE; PLASMA VOLUME; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM TRANSPORT;

AFRICAN CONTINENTAL ANCESTRY GROUP; APOLIPOPROTEINS; BLOOD PRESSURE; HUMANS; HYPERTENSION; KIDNEY; LIPOPROTEINS, HDL; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; RENIN-ANGIOTENSIN SYSTEM; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS;

EID: 84879605730     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0332-9     Document Type: Review

References (55)

1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-50.
2. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35:426-31.
3. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. New Engl J Med. 1982;306:1276-9.
4. Helmer OM, Judson WE. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosternosm. Circulation. 1968;38:965-76.
5. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(Suppl II):II-12-134.
6. Pratt JH, Jones JJ, Miller JZ, Wagner MA, Fineberg NS. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. New Engl J Med. 1989;321:1152-7.
7. Grim CE, Luft FC, Miller JZ, Meneely GR, Battarbee HD, Hames CG, et al. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chron Dis. 1979;33:87-94.
8. Turban S, Miller 3rd ER, Ange B, Appel LJ. Racial differences in urinary potassium excretion. J Am Soc Nephrol. 2008;19:1396-402.
9. Aviv A, Hollenberg NK, Weder A. Urinary potassium excretion and sodium sensitivity in blacks. Hypertension. 2004;43:707-13.
10. Klevay LM, Bogden JD, Aladjem M, Sandstead HH, Kemp FW, Li W, et al. Renal and gastrointestinal potassium excretion in humans: New insight based on new data and review and analysis of published studies. J Am Coll Nutr. 2007;26:103-10.
11. Chrysant SG, Danisa K, Kem DC, Dillard BL, Smith WJ, Frohlich ED. Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension. 1979;1:136-41.
12. Pratt JH, Manatunga AK, Bloem LJ, Wei L. Racial differences in aldosterone excretion: a longitudinal study in children. J Clin Endocrinol Metabol. 1993;77:1512-5.
13. •• Zou LX, Imig JD, Von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-induced rats. Hypertension. 1996;28:669-77. Work from this laboratory showed that there is an intra-renal RAS.
14. Navar LG. The kidney in blood pressure regulation and development of hypertension. Med Clin. 1997;81:1165-98.
15. •• Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, et al. Regulation of blood pressure by the type 1a angiotensin II receptor gene. Proc Natl Acad Sci. 1995;92:3521-5. Elegant mouse model studies that delineated a role for intra-renal RAS to regulate blood pressure.
16. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci. 1995;92:2735-9.
17. •• Jeunemaitre X, Soubrier F, Kotelevtev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-80. A landmark paper demonstrating for the first time common variations in a gene associating with hypertension.
18. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension. 1997;29:1078-82.
19. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Investig. 1995;95:948-53.
20. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. New Engl J Med. 1994;330:1629-33.
21. Schorr U, Blaschke K, Beige J, Distler A, Sharma AM. Angiotensinogen M235T variant and salt sensitivity in young normotensive caucasians. J Hypertens. 1999;17:475-9.
22. Wright Jr JT, Bakris G, Aask, Greene T, Agodoa LY, Appel LJ, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA. 2002;288:2421-31.
23. Greger R. Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron. Physiol Rev. 1985;65:760-97.
24. Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the jutaglomerular complex wih hyperaldosteronism and hypokalemic alkalosis. Am J Med. 1962;33:811-28.
25. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the na-k-2cl cotransporter nkcc2. Nat Genet. 1996;13:183-8.
26. Simon DB, Karet FE, Rodriquez-Soriano J, Hamdan JH, DePietro A, Trachtman H, et al. Genetic heterogeneithy of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet. 1996;14:152-6.
27. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause bartter's syndrome type III. Nat Genet. 1997;17:171-8.
28. Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, et al. Mutation of bsnd causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet. 2001;29:310-4.
29. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet. 2002;360:692-4.
30. Wigertz K, Palacios C, Jackman LA, Martin BR, McCabe LD, McCabe GP, et al. Racial differences in calcium retention in response to dietary salt in adolescent girls. Am J Clin Nutr. 2005;81:845-50.
31. Pratt JH, Manatunga AK, Peacock M. A comparison of the urinary excretion of bone resorptive products in white and black children. J Lab Clin Med. 1996;127:67-70.
32. Chun TY, Bankir L, Eckert GJ, Bichet DG, Saha C, Zaidi SA, et al. Ethnic differences in renal responses to furosemide. Hypertension. 2008;52:241-8.
33. Hebert SC, Andreoli TE. Control of nacl transport in the thick ascending limb. Am J Physiol. 1984;246:F745-56.
34. Jung J, Foroud TM, Eckert GJ, Flury-Wetherill L, Edenberg HJ, Xuei X, et al. Association of the calcium-sensing receptor gene with blood pressure and urinary calcium in African-Americans. J Clin Endocrinol Metab. 2009;94:1042-8.
35. Bankir L, Perucca J, Weinberger MH. Ethnic differences in urine concentration: possible relationship to blood pressure. Clin J Am Soc Nephrol. 2007;2:304-12.
36. Hancock ML, 2nd, Bichet DG, Eckert GJ, Bankir L, Wagner MA, Pratt JH. Race, sex and the regulation of urine osmolality-observations made during water deprivation. Am J Physiol Regul Integr Comp Physiol. 2010
37. Weder AB, Gleiberman L, Sachdeva A. Whites excrete a water load more rapidly than blacks. Hypertension. 2009;53:715-8.
38. Baker EH, Dong YB, Sagnella GA, Roghwell M, Onnipinla AK, Markandu ND, et al. Association of hypertension with T594M mutation in á subunit of epithelial sodium channels in black people resident in london. Lancet. 1998;351:1388-92.
39. Ambrosius WT, Bloem LJ, Zhou L, Rebhun JF, Snyder PM, Wagner MA, et al. Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension. 1999;34:631-7.
40. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension. 2002;40:903-8.
41. • Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension. 2005;46:481-7. Demonstration of the effectiveness of ENaC inhibition to lower blood pressure in blacks.
42. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:3266-81.
43. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
44. • El Gharbawy AH, Nadig VS, Kotchen JM, Grim CE, Sagar KB, Kaldunski M, et al. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension. 2001;37:845-50. Important paper showing that development of hypertension in blacks, not whites, is coincident with excess aldosterone relative to volume, as expressed in the aldosterone/renin ratio.
45. • Michel FS, Norton GR, Majane OH, Badenhorst M, Vengethasamy L, Paiker J, et al. Contribution of circulating angiotensinogen concentrations to variations in aldosterone and blood pressure in a group of African ancestry depends on salt intake. Hypertension. 2012;59:62-9. New observation implicating a role for aldosterone to mediate the effects of angiotensinogen on blood pressure in blacks.
46. Czirjak G, Fischer T, Spat A, Lesage F, Enyedi P. Task (twik-related acid-sensitive k+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II. Mol Endocrinol. 2000;14:863-74.
47. Czirjak G, Enyedi P. Task-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol. 2002;16:621-9.
48. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, et al. Task channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci. 2008;105:2203-8.
49. Jung J, Barrett PQ, Eckert GJ, Edenberg HJ, Xuei X, Tu W, Pratt JH. Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory study. J Clin Endocrinol Metab. 2012;97(11):E2160-7
50. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40:1185-92.
51. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40:1175-84.
52. •• Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic apol1 variants with kidney disease in African Americans. Science. 2010;329:841-5. Showed for the first time that a clear survival advantage led eventually to a high frequency of kidney disease.
53. Friedman DJ, Pollak MR. Genetics of kidney failure and the evolving story of APOL1. J Clin Invest. 2011;121:3367-74.
54. Loria AS, Pollock DM, Pollock JS. Early life stress sensitizes rats to angiotensin II-induced hypertension and vascular inflammation in adult life. Hypertension. 2010;55:494-9.
55. Cowley Jr AW, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH, et al. Report of the National Heart, Lung, and Blood Institute Working Group on Epigenetics and Hypertension. Hypertension. 2012;59:899-905.